Skip to content
Swanley Therapy Centre

Swanley Therapy Centre

Swanley Unit for Multiple Sclerosis [S.U.M.S.]

apply here
donate

Menu

  • Home
  • Services
    • Oxygen Therapy
    • Bowen Therapy
    • Pilates
    • Lily Lou Beauty
    • MS Support
  • Fundraising
    • Donations
    • Fundraising Events
    • Supporters & Donators
    • Volunteering
  • News
    • Blog
    • Testimonials
    • Newsletter
  • About Us
    • Gallery
    • Meet The Team
    • Volunteer Team
    • Therapists
  • How to Find Us
  • FAQ’s
  • facebook
  • twitter
  • instagram
Search

Posts in the MS News category:

General, MS News

Effect of vitamin D supplements on MS activity

Written by Ellen on February 27th, 2020December 8th, 2021.

People with MS are often advised to take high doses of vitamin D, but there’s been very little research to assess what effect this might have.

Continue Reading Effect of vitamin D supplements on MS activity
General, MS News

The Evidence for Oxygen awarded the 2019 Nobel prize

Written by Ellen on January 29th, 2020December 8th, 2021.

We wanted to draw attention to an interesting article published in the HBOTT Dec 2019 Newsletter.

Continue Reading The Evidence for Oxygen awarded the 2019 Nobel prize
General, MS News

Tysabri: reducing the risk of PML with extended interval dosing

Written by Ellen on December 12th, 2019December 8th, 2021.

Tysabri (natalizumab) is very effective for people with highly active relapsing remitting MS but it carries the risk of developing a rare but very serious brain infection called progressive multifocal […]

Continue Reading Tysabri: reducing the risk of PML with extended interval dosing
General, MS News

Sativex approved by NICE

Written by Ellen on November 20th, 2019December 8th, 2021.

Sativex, a cannabis based drug for MS related spasticity, has been approved by NICE as a cost effective treatment for the NHS in England.

Continue Reading Sativex approved by NICE
General, MS News

Siponimod recommended for secondary progressive MS by EMA

Written by Ellen on November 20th, 2019December 8th, 2021.

The European Medicines Agency has recommended that a licence should be granted for Siponimod for the treatment of active secondary progressive MS.

Continue Reading Siponimod recommended for secondary progressive MS by EMA
General, MS News

Rex Robotic Exoskeleton Trial

Written by Ellen on August 29th, 2019December 8th, 2021.

East Kent leads the way in robotic trials to improve patients’ mobility.

Continue Reading Rex Robotic Exoskeleton Trial

Swanley Therapy Centre [HDOT]

Unit 8
Park Road Industrial Estate
Swanley
Kent BR8 8AH

01322 663042

Disabled Access

Registered Charity No: 801112
Registered Company No: 2345991

opening times

swanley-oxygen-treatment-centre

Tuesday: 9am-2pm
Wednesday: 9am-2pm; 7pm-8:30pm
Thursday: 9am-2pm
Saturday: 9am-2pm

Follow us on:

Visitors to date:

781852
  • Site Map
  • How to Find Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy (UK)
© Copyright 2023 Swanley Therapy Centre . All Rights Reserved.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}